Population pharmacokinetics and dosing considerations of daptomycin in critically ill patients undergoing continuous renal replacement therapy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Population pharmacokinetics and dosing considerations of daptomycin in critically ill patients undergoing continuous renal replacement therapy
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2020-01-18
DOI
10.1093/jac/dkaa028
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Population pharmacokinetics of daptomycin in critically ill patients
- (2018) A. Soraluce et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Continuous Renal Replacement Therapy – Who, When, Why and How
- (2018) Srijan Tandukar et al. CHEST
- The eICU Collaborative Research Database, a freely available multi-center database for critical care research
- (2018) Tom J. Pollard et al. Scientific Data
- Daptomycin
- (2017) Mohsen Heidary et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Population pharmacokinetics of daptomycin in adult patients undergoing continuous renal replacement therapy
- (2016) Xiaoying Xu et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Daptomycin Pharmacokinetics and Pharmacodynamics in Septic and Critically Ill Patients
- (2016) Antonio D’Avolio et al. DRUGS
- Improving the estimation of parameter uncertainty distributions in nonlinear mixed effects models using sampling importance resampling
- (2016) Anne-Gaëlle Dosne et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Pharmacokinetic/pharmacodynamic considerations for the optimization of antimicrobial delivery in the critically ill
- (2015) Danny Tsai et al. Current Opinion in Critical Care
- The effect of pathophysiology on pharmacokinetics in the critically ill patient — Concepts appraised by the example of antimicrobial agents
- (2014) Stijn I. Blot et al. ADVANCED DRUG DELIVERY REVIEWS
- Pharmacokinetics of Daily Daptomycin in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy
- (2013) Natascia Corti et al. CHEMOTHERAPY
- Clinical and pharmacokinetic considerations for the use of daptomycin in patients with Staphylococcus aureus bacteraemia and severe renal impairment
- (2013) Ricardo L. Chaves et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Management of renal replacement therapy in ICU patients: an international survey
- (2012) Matthieu Legrand et al. INTENSIVE CARE MEDICINE
- Daptomycin serum levels in critical patients undergoing continuous renal replacement
- (2012) Marco Falcone et al. JOURNAL OF CHEMOTHERAPY
- Daptomycin: A Review of Properties, Clinical Use, Drug Delivery and Resistance
- (2012) C. Vilhena et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects Models
- (2011) Martin Bergstrand et al. AAPS Journal
- Plasma pharmacokinetics of daptomycin in critically ill patients with renal failure and undergoing CVVHD
- (2011) D. Khadzhynov et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Multiple-dose pharmacokinetics of daptomycin during continuous venovenous haemodiafiltration
- (2011) J. M. Wenisch et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The rising problem of antimicrobial resistance in the intensive care unit
- (2011) Nele Brusselaers et al. Annals of Intensive Care
- Daptomycin Exposure and the Probability of Elevations in the Creatine Phosphokinase Level: Data from a Randomized Trial of Patients with Bacteremia and Endocarditis
- (2010) Sujata M. Bhavnani et al. CLINICAL INFECTIOUS DISEASES
- Daptomycin pharmacokinetics in critically ill patients receiving continuous venovenous hemodialysis
- (2010) A. Mary Vilay et al. CRITICAL CARE MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started